UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000002466
Receipt number R000003019
Scientific Title Multi-Center Phase II Clinical Trial on Efficacy and Safety of Interferon Alfa-n1 + Sorafenib Combination Therapy in Renal Cell Carcinoma
Date of disclosure of the study information 2009/09/09
Last modified on 2014/04/08 10:42:14

No. Disposal Last modified on Item of update
1 Insert 2009/09/07 19:05:34
2 Update 2009/09/11 13:04:22 Recruitment status
3 Update 2009/09/11 13:57:57 UMIN ID1
4 Update 2009/09/11 15:54:42 Institutions
5 Update 2009/09/11 20:10:08 Key inclusion criteria
Key exclusion criteria
6 Update 2009/09/11 20:11:39 Institutions
7 Update 2009/12/22 10:26:04 Recruitment status
8 Update 2010/09/09 12:18:59 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
9 Update 2010/09/09 12:26:54 Name of person sending information
Organization
Division name
Address
Institutions
10 Update 2010/10/19 16:07:54 Institutions
11 Update 2011/05/07 22:37:12 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
12 Update 2011/09/09 11:48:50 Post marketing survey by drug manufacture etc., specified by Japanese law.
13 Update 2013/03/08 12:28:34 Recruitment status
14 Update 2013/03/08 12:42:22 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
15 Update 2014/04/08 10:42:14 Recruitment status